Systematic review of new drug research and development (R&D) costWANG Qing-hua, HUANG Run-qing, LI Fan, LIU Guo-en601-608
A new drug for solid tumors harbouring NTRK fusions in adults and children: larotrectinibCHEN Su-hua, ZHANG Yan-hua609-613
Considerations for application of early clinical trials of anti-tumor drugs for use in combinationZOU Li-min, TANG Ling, QI Yue-li, ZHOU Ming, XIA Lin, CHEN Dong-mei, SONG Yuan-yuan, ZHANG Hong, TONG Xin, HAO Rui-min, ZHAO Xiao, YANG Zhi-min614-617
Research progress on in vitro alternative method of eye irritation evaluationQIAN Yi-min, WANG Ruo-nan, LI Hua, MA Jing618-623
Application of 3D cell culture technology in toxicology researchWANG Jing-ting, ZHOU Chang-hui, CHANG Yan624-628
Advance in research of drug carriers based on γ-cyclodextrin metal-organic frameworkXUE Qian, HU Xiong-wei, CAI Ting629-633
Research progress of oral film and an introduction to commercial productsJIANG Zhuo-qin, JIANG Chang-zhao, YE Jin-cui, YANG Gen-sheng634-641
Effects of butylphthalide on serum levels of TNF-α, IL-8 and serum uric acid in the treatment of vascular congnitive impairmentSUN Yan-jie, LIU Na, LI Xin, DUAN Rui-sheng651-654
Virtual screening of antagonists for mineralocorticoid receptorWANG Ying-ying, LIU Wei, MENG Fan-cui, TANG Li-da655-661